Cyclopharm Limited announced a private placement of 100,000 common shares at an issue price of AUD 2.18 for the gross proceeds of AUD 218,000 on April 17, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.65 AUD | +5.77% | -0.90% | -14.29% |
Mar. 19 | Cyclopharm's Technegas Device Carries Out Imaging of First US Patients | MT |
Mar. 18 | Cyclopharm Limited(ASX:CYC) added to S&P/ASX All Ordinaries Index | CI |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-14.29% | 98M | |
+11.18% | 225B | |
+15.22% | 197B | |
+19.19% | 143B | |
+30.89% | 111B | |
+2.47% | 64.72B | |
+18.48% | 54.44B | |
+5.12% | 51.06B | |
+10.53% | 45.03B | |
+5.98% | 37.4B |
- Stock Market
- Equities
- CYC Stock
- News Cyclopharm Limited
- Cyclopharm Limited announced that it expects to receive AUD 0.218 million in funding